1. The FDA approved the first interoperable insulin pump, Tandem Diabetes Care t:Slim X2 insulin pump, for delivering insulin for children and adults with diabetes.
2. Egaten is the first treatment to treat fascioliasis, a rare tropical disease also called liver fluke infestation. The disease is caused by two species of parasitic flatworms that infect people after they consume its larvae in contaminated water.
3. The FDA approved a split-dosing regimen for Darzalex, a multiple myeloma treatment. The new approval allows patients to split the infusion over two consecutive days.
4. Cablivi is a injection for the treatment of acquired thrombotic thrombocytopenic purpura, a rare blood disorder.
More articles on supply chain:
Facebook to help connect hospitals to blood donors
FDA commissioner suggests blockchain technology to improve drug traceability
An injection for a blood clotting disorder, a rival Botox treatment & more: 4 recent FDA approvals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
